The Biochemical and Neurologic Basis for the Treatment of Male Erectile Dysfunction
- 1 February 2001
- journal article
- review article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 296 (2) , 225-234
- https://doi.org/10.1016/s0022-3565(24)38739-7
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- INCIDENCE OF ERECTILE DYSFUNCTION IN MEN 40 TO 69 YEARS OLD: LONGITUDINAL RESULTS FROM THE MASSACHUSETTS MALE AGING STUDYJournal of Urology, 2000
- Alpha‐Adrenergic Receptors in the Penis: Identification, Characterization, and Physiological Function MinireviewJournal of Andrology, 1999
- THE EFFECT OF SILDENAFIL ON APOMORPHINE-EVOKED INCREASES IN INTRACAVERNOUS PRESSURE IN THE AWAKE RATJournal of Urology, 1999
- Sexual Dysfunction in the United StatesJAMA, 1999
- THE EPIDEMIOLOGY AND PATHOPHYSIOLOGY OF ERECTILE DYSFUNCTIONJournal of Urology, 1999
- Signal transduction in cavernous smooth muscleWorld Journal of Urology, 1997
- Neuromodulation of penile erection: an overview of the role of neurotransmitters and neuropeptidesProgress in Neurobiology, 1995
- Dopamine and sexual behaviorNeuroscience & Biobehavioral Reviews, 1995
- Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging StudyJournal of Urology, 1994
- Role of GABA during the multiple consolidation of memoryDrug Development Research, 1993